Ekso Bionics Holdings Profit Margin

The latest profit margin for EKSO is -108.77% as of August 2026. That compares with -75.66% in the prior-year period — down 43.8% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside Ekso Bionics Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, EKSO's profit margin moved from -75.66% to -108.77% — a 43.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ekso Bionics Holdings's valuation or profitability profile.

Against Healthcare companies, EKSO currently prints -108.77% for profit margin, while the sector average sits near 19.13%. That is roughly 668.6% below the sector mean. Large gaps often invite a closer look at Ekso Bionics Holdings's growth, margins, and balance sheet.

Profit Margin shows how effectively Ekso Bionics Holdings converts resources into returns. At -108.77%, EKSO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -75.66% in the prior-year period — down 43.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting EKSO's profit margin (-108.77%), review year-over-year change from -75.66%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.